REED's, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by REED's, INC. on March 14, 2022, covering events occurring on March 10, 2022. The filing details a material definitive agreement involving a private placement of equity securities to raise capital for general corporate purposes.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $5.4 million.
- Securities Issued: 18,594,571 shares of Common Stock and warrants to purchase 9,297,289 shares.
- Purchase Price: $0.28 per share (plus warrant) for institutional investors; $0.3502 per share (plus warrant) for officers and directors.
- Warrant Terms: Exercise price of $0.2877 per share; exercisable for five years commencing six months post-closing.
- Insider Participation: Officers and directors purchased approximately $1.1 million of the securities.
- Placement Agent Fee: 6.5% of gross proceeds paid to Roth Capital Partners, LLC.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement. Under the Registration Rights Agreement, the Company agreed to file a Form S-3 registration statement within 45 days of the closing to register the resale of the shares and warrant-issued shares. The transaction closed on March 11, 2022. The filing text does not provide comparative financial metrics (revenue, profit, cash flow) as this is a transactional report rather than a periodic financial statement.
Outlook, Risks, and Use of Proceeds
The Company intends to use the net proceeds for general working capital and general corporate purposes. A 90-day lock-up period prohibits the issuance of additional common stock or equivalents, with exceptions for equity compensation plans and outstanding rights. The agreements include customary penalties and liquidated damages for failure to meet registration filing deadlines or legend removal requirements.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 6.5% placement agent fee and other offering expenses.
- Confirm the filing of the Form S-3 registration statement within the required 45-day window.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and liquidated damages clauses.
- Monitor the Company's capital structure for potential dilution upon warrant exercise.